2025 consolidated revenue rose 25.1% year-on-year to KRW385.9 billion from KRW308.6 billion in 2024, while operating profit fell 3.4% to KRW40.8 billion from KRW42.2 billion, pulling the operating margin down from 13.7% to 10.6%.
Owner-attributable net income also declined, from KRW27.3 billion in 2024 to KRW23.9 billion in 2025, reflecting a larger share of profit allocated to non-controlling interests after the March 2025 consolidation of Lion Chemtech, in which the combined stake was only 55.58%.
Owner's equity rose from KRW215.2 billion in 2024 to KRW235.5 billion in 2025, while non-controlling interests nearly doubled from KRW96.7 billion to KRW184.4 billion, and total liabilities rose from KRW73.7 billion to KRW206.1 billion, lifting the debt ratio from 23.6% to 49.1%.
In contrast, operating cash flow improved substantially, rising to KRW64.5 billion in 2025 from KRW38.9 billion in 2024, showing stronger cash generation relative to reported earnings.
On a quarterly basis, operating profit peaked at KRW12.2 billion in the third quarter of 2025, the highest of the recent five quarters, before easing to KRW9.4 billion in the fourth quarter.
Into 2026, operating profit came in at KRW10.8 billion in the first quarter and KRW9.9 billion in the second, while owner-attributable net income reached KRW9.9 billion in the first quarter — the highest of the five-quarter window — before falling to KRW6.5 billion in the second quarter, a divergence between the operating-profit and owner-profit trends.
Over the most recent four quarters (Q3 2025 through Q2 2026), revenue totaled roughly KRW427.3 billion, operating profit about KRW42.3 billion, and owner-attributable net income about KRW27.7 billion.
These figures indicate that while revenue expansion has continued, growth in profit attributable to controlling shareholders has been comparatively muted.